LIPOSOMA is global market leader for clodronate liposomes for preclinical immunological research. Clodronate liposomes can efficiently and safely eliminate macrophages in vivo and they are a widely applied tool for macrophage depletion. After administration the liposomes are phagocytosed by macrophages, delivering their clodronate content intracellularly and leading to macrophage apoptosis and their depletion from the tissue.
Please visit Clodronate Liposomes Website for product information, online ordering, distributor information, background information and dosing schedules.